Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Vitrafy Life Sciences Ltd. ( (AU:VFY) ) has provided an update.
Vitrafy Life Sciences Limited has announced the appointment of Jeannette (Jeannie) Joughin as a director of the company, effective 20 January 2026, in line with its disclosure obligations as an ASX-listed entity. The company reported that Joughin currently holds no direct or indirect interests in Vitrafy securities and has no interests in contracts relating to its securities, signalling a starting position free of equity holdings as she joins the board.
The most recent analyst rating on (AU:VFY) stock is a Buy with a A$2.10 price target. To see the full list of analyst forecasts on Vitrafy Life Sciences Ltd. stock, see the AU:VFY Stock Forecast page.
More about Vitrafy Life Sciences Ltd.
Vitrafy Life Sciences Limited is an Australian-listed company in the life sciences sector. The release does not specify its precise products, services or market focus beyond its listing on the ASX and standard corporate governance obligations.
Average Trading Volume: 34,217
Technical Sentiment Signal: Buy
Current Market Cap: A$95.77M
For detailed information about VFY stock, go to TipRanks’ Stock Analysis page.